Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders have?
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders has 80 citations in the OpenAlex counts ScholarIQ stores.
When was Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders published?
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders has 2020 year in the ScholarIQ index.
What is the open-access status of Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders?
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders has hybrid oa status in the ScholarIQ index.
What is the DOI of Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders?
The DOI for Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders is on the source record.
What is the PMID of Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders?
The PMID for Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders is on the source record.
What is the OpenAlex record for Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders?
The OpenAlex for Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders is on the source record.